Novel late-stage colorectal cancer treatment proves effective in preclinical models
by Angel Mendez,University of Minnesota Medical SchoolThe low T cells are due to exosomal, immunosuppressive miRNAs that disrupt T cell function and loss of T cells in the tumor environment. Cre
Updated on: April 29,2024
13
Novel late-stage colorectal cancer treatment proves effective in preclinical models
by Angel Mendez,University of Minnesota Medical SchoolThe low T cells are due to exosomal, immunosuppressive miRNAs that disrupt T cell function and loss of T cells in the tumor environment. Cre
Updated on:April 29,2024
13